Shares of Vitamin Shoppe, Inc (NYSE:VSI) have earned a consensus rating of “Hold” from the eleven brokerages that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell rating and eight have given a hold rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $13.83.

Several brokerages recently weighed in on VSI. Goldman Sachs Group, Inc. (The) reissued a “sell” rating and issued a $6.00 price objective (down previously from $13.00) on shares of Vitamin Shoppe in a report on Thursday. Barclays PLC decreased their price objective on Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating for the company in a report on Thursday. Morgan Stanley set a $8.00 price objective on Vitamin Shoppe and gave the stock a “hold” rating in a report on Thursday. TheStreet lowered Vitamin Shoppe from a “c-” rating to a “d” rating in a report on Wednesday, August 9th. Finally, Deutsche Bank AG reissued a “hold” rating and issued a $7.00 price objective (down previously from $14.00) on shares of Vitamin Shoppe in a report on Thursday.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/08/14/analysts-set-vitamin-shoppe-inc-vsi-pt-at-13-83.html.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Arizona State Retirement System increased its position in shares of Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares in the last quarter. Texas Permanent School Fund increased its stake in shares of Vitamin Shoppe by 0.8% in the second quarter. Texas Permanent School Fund now owns 17,389 shares of the specialty retailer’s stock worth $203,000 after buying an additional 145 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock worth $108,000 after buying an additional 192 shares during the period. Mason Street Advisors LLC increased its stake in shares of Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after buying an additional 366 shares during the period. Finally, Capstone Asset Management Co. increased its stake in shares of Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock worth $164,000 after buying an additional 470 shares during the period.

Shares of Vitamin Shoppe (NYSE VSI) traded up 4.435% during midday trading on Friday, hitting $6.475. 665,353 shares of the stock were exchanged. The firm’s market capitalization is $150.42 million. The stock’s 50-day moving average price is $10.47 and its 200-day moving average price is $15.91. Vitamin Shoppe has a 1-year low of $5.75 and a 1-year high of $28.56.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the consensus estimate of $0.39 by $0.16. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The firm had revenue of $304.84 million during the quarter, compared to analysts’ expectations of $314.74 million. During the same period last year, the business posted $0.55 EPS. The company’s revenue was down 8.4% compared to the same quarter last year. On average, analysts forecast that Vitamin Shoppe will post $0.98 EPS for the current year.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.